ABSI250117P5000
- 0.00
- 0.000.00%
Absci Corp Newsroom
Absci Partners With Owkin to Develop Immuno-oncology Treatment Candidates
Express News | Absci and Owkin Synergize Leading Techbio Platforms to Advance Generative AI Drug Discovery
Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Absci Is Maintained at Overweight by Keybanc
Keybanc Maintains Overweight on Absci, Lowers Price Target to $5
H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $7
HC Wainwright & Co. Maintains Buy on Absci, Maintains $7 Price Target
Absci Analyst Ratings
U.S. stock market early session | All three major Indexes fell, most Growth Tech stocks weakened, NVIDIA and Microsoft rose nearly 1% against the trend, while AMD dropped over 4%.
On the evening of the 8th in Peking time, US stocks opened lower on Wednesday. Concerns regarding the interest rate cut path led to a decline in US stocks yesterday, and the market is focusing on the Federal Reserve's monetary policy meeting minutes in December. The December ADP private employment data in the USA was below market expectations. The President-elect Trump is considering declaring a national economic emergency to promote new tariff policies.
AAR Posts Upbeat Results, Joins AngioDynamics, EBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday
AMD (AMD.US) invests in the startup Absci (ABSI.US) involved in the Medical Care sector.
AMD (AMD.US) announced a new partnership and investment with the startup Absci Corp (ABSI.US). Absci stated that it has received a $20 million investment from AMD to advance its product line. Absci's stock price rose 13% in the early hours of Wednesday. Absci indicated that the structure of this investment is a private investment in public equity, known as a PIPE Trade. AMD will support Absci in using its chips and software to create better biologics for patients, reduce infrastructure costs, and accelerate the innovation cycle. This is AMD's first investment in the Medical Care sector.
Market Update | AI drug development company Absci surged over 20%, receiving a $20 million investment from AMD.
Absci (ABSI.US) has received a $20 million investment from AMD (AMD.US) in the form of private equity (PIPE).
4 Stocks to Watch on Wednesday: EBAY, CART and More
Sector Update: Health Care Stocks Rise Premarket Wednesday
US Equity Futures Turn Lower Pre-Bell as Investors Eye Fed Minutes
KeyBanc Maintains Absci Corp(ABSI.US) With Buy Rating, Cuts Target Price to $5
US Stock Outlook | "ADP Employment Report" falls short of expectations! The three major futures indices show slight gains; boosted by AMD's bullish investment, AI startup ABSI rises over 40% in pre-market trading.
According to informed sources, Trump is considering declaring a national economic emergency to launch a new tariff plan; Federal Reserve Governor Waller: supports further interest rate cuts this year; Federal Reserve's Bostic: inflation will gradually decline, policymakers should remain cautious in their decision-making.
Abscri Shares Are Trading Higher After the Company Announced a Strategic Collaboration With AMD. Abscri Will Receive a $20 Million Investment as Part of the Deal.
Top Premarket Gainers